Perjeta 420 MG/14 ML vial 14ML
Ended Awarded
- Contract number
- SPE2DX25F6AGG
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $91,145
Award facts
- Contract value 100% obligated
- $91,145.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA), operating under the Medical Supply Chain, awarded a delivery order valued at $91,145.20 to DMS Pharmaceutical Group Inc. on September 16, 2025, for the supply of Perjeta 420 mg/14 mL vials. This firm fixed-price delivery order is scheduled for completion by October 7, 2025, with performance taking place at the contractor's location in Park Ridge, Illinois. The award was made without a set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the federal marketplace leveraging its status as a woman-owned small business.
DMS Pharmaceutical Group Inc., a pharmaceutical wholesaler established in 2001, serves as a critical supplier within the federal pharmaceutical supply chain, distributing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare facilities. This delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499.999 billion and extending through November 2026. This IDC framework enables the DLA to issue firm fixed-price delivery orders for comprehensive pharmaceutical products supporting military health facilities worldwide, positioning DMS Pharmaceutical Group as a significant vendor for oncology treatments, specialty medications, and other critical pharmaceutical supplies to DoD healthcare systems.
Quick answers
Who was awarded contract SPE2DX25F6AGG?
SPE2DX25F6AGG was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 16, 2025.
How much is contract SPE2DX25F6AGG worth?
The government has obligated $91,145 on SPE2DX25F6AGG.
Is contract SPE2DX25F6AGG an order under another contract?
Yes. SPE2DX25F6AGG is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6AGG competed?
The extent of competition for SPE2DX25F6AGG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award